Fig. 4.
Probability of developing proven or probable IA late after onset of acute GVHD, diagnosis of CMV disease, or receipt of corticosteroids.
Panel A shows probabilities for patients with acute GVHD (aGVHD) grade 1 or 2 and those with aGVHD grade 3 or 4. Panel B shows CMV disease, and panel C shows probability according to dose of corticosteroids administered.